By analyzing these data across more than 100,482 individuals, they identified two significant single-nucleotide polymorphisms (SNPs) (rs66838809 and rs1107748) in the SOST region, with robust evidence linking lower sclerostin levels to increased coronary artery disease risk. Here, SOST is linked to coronary artery disorder.